CPhI Pharma Insights Report - USA

This CPhI report announces the findings from a comprehensive review of the Unites States of America pharmaceutical manufacturing. The US pharma industry and domestic manufacturers are showing increased confidence of renewed growth and even the returning of some lower cost manufacturing work that has, in previous years, been outsourced overseas. This turnaround in the US market’s revenue potential is being driven by concerns of quality in some Asian markets and a marked shift in the drug development pipeline towards difficult to formulate drugs and biosimilars.

 

Download the report here:

CPhI Pharma Insights - USA Report